CD44 and neoplasm: We have previously shown that fastuosain, a cysteine-protease from Bromelia fastuosa protected mice against murine melanoma B16F10-Nex2 subcutaneous development, mainly by reduction of CD44 expression, which led to decreased tumor cell invasion [11].